Swayampakula Ramakanth

Stock Analyst at HC Wainwright & Co.

(0)
# 3986
Out of 5,218 analysts
527
Total ratings
33.91%
Success rate
-2.90%
Average return
87 Stocks
Name Action Price Target Current % Upside Ratings Updated
Absci
Reiterates: Buy
7 7
3.7 89.19% 10 Dec 13, 2024
Elevation Oncology
Reiterates: Buy
6 6
0.64 837.5% 6 Dec 13, 2024
ITeos Therapeutics
Reiterates: Buy
21 21
7.67 173.79% 9 Dec 13, 2024
ImmunoPrecise Antibo...
Maintains: Buy
9 7
0.4 1650% 8 Dec 11, 2024
Vor Biopharma
Reiterates: Buy
18 18
0.98 1685.71% 10 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
2.13 369.48% 12 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
3.06 275.82% 12 Dec 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 10 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
63 70
61.1 14.57% 11 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
3.74 194.12% 11 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 25
17.14 45.86% 16 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
11 15
12.31 21.85% 4 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8
0.29 2658.62% 13 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
2.04 145.1% 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
1.63 329.45% 6 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
4 6
1.73 217.92% 5 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
27 27
12.47 116.52% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
0.68 488.24% 8 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
2.96 85.81% 12 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
0.64 134.38% 12 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.87 704.6% 17 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
1.65 687.88% 5 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
23.76 68.35% 4 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
12.09 81.97% 10 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
57.49 4.37% 16 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
1.15 1117.39% 9 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
55 55
13.8 298.55% 15 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
55.4 44.4% 17 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
0.57 1478.95% 12 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
2.19 767.58% 13 Aug 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
0.57 66.67% 4 Aug 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 9
3.84 134.38% 10 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
1.45 1624.14% 11 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
1.79 95.53% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1 1
n/a n/a 11 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
9.17 19.96% 8 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
2.78 619.42% 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.63 693.65% 5 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
13.72 9.33% 11 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 23
n/a n/a 9 Jan 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
4.93 82.56% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 32
n/a n/a 10 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 12 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 6 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
n/a n/a 3 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 12 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9
1.12 703.57% 1 Feb 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
150 25
2.25 1011.11% 2 Jan 30, 2023